Department of Gynecology, First Affiliated Hospital of Xinjiang Medical University,
Urumqi, Xinjiang Province, China
Department of General Surgery, First Affiliated Hospital of Xinjiang Medical University,
Urumqi, Xinjiang, China
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=255). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.
Please download to know all details of the Special Issue
Gynecologic cancer is a group of cancers that affect the tissue and organs of the female reproductive system. Each type of cancer is named after the organ it originates including, ovarian cancer, cervical cancer, uterine cancer, vulvar cancer and, vaginal cancer. Each gynecologic cancer is unique, with different signs and symptoms, risk factors and different preventive strategies.
Aims and Scope: 1. Though a grave health issue in women, it is highly needed to provide an insight on the furtherance of gynecologic oncology. 2. To come up more clearly with the need of educational intervention regarding gynecologic cancer in different communities. 3. Comprehensive and novel prevention and early detection strategies, and scientific pursuits to improve the standard of practice will yield the end of suffering and death due to gynecologic cancer.